Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Maneval

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cancer Gene Therapy|February 26, 1998
P53 tumor suppressor gene therapy for cancerL L Nielsen, D C Maneval
European Journal of Nuclear Medicine|January 1, 1990
A kinetic model for 99mTc-DMSA in the ratD C Maneval, D Z D'Argenio, W Wolf
Oncogene|April 18, 1996
Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinomaK Mujoo, D C Maneval, S C Anderson, et al.
Pharmacotherapy|January 1, 1993
Measurement of Tc-99m DTPA serum clearance for estimating glomerular filtration rate in children with cancerJ H Rodman, D C Maneval, H L Magill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1990
Measurement of skin-to-kidney distance in children: implications for quantitative renographyD C Maneval, H L Magill, A M Cypess, et al.
Acta Haematologica|April 15, 1999
Adenovirus p53 purging for human breast cancer stem cell productsM Hirai, L S Kelsey, D C Maneval, et al.
Handbook of Experimental Pharmacology|December 12, 2007
HerceptinH M Shepard, P Jin, D J Slamon, et al.
Annals of Internal Medicine|January 1, 1982
Hepatic veno-occlusive disease caused by 6-thioguanineR A Gill, G R Onstad, J M Cardamone, et al.
Cancer Gene Therapy|April 19, 2000
Purging of human breast cancer cells from stem cell products with an adenovirus containing p53M Hirai, L S Kelsey, M Vaillancourt, et al.
Cancer Gene Therapy|August 7, 1998
A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growthG W Demers, M P Harris, S F Wen, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cancer Gene Therapy|February 26, 1998
P53 tumor suppressor gene therapy for cancerL L Nielsen, D C Maneval
European Journal of Nuclear Medicine|January 1, 1990
A kinetic model for 99mTc-DMSA in the ratD C Maneval, D Z D'Argenio, W Wolf
Oncogene|April 18, 1996
Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinomaK Mujoo, D C Maneval, S C Anderson, et al.
Pharmacotherapy|January 1, 1993
Measurement of Tc-99m DTPA serum clearance for estimating glomerular filtration rate in children with cancerJ H Rodman, D C Maneval, H L Magill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1990
Measurement of skin-to-kidney distance in children: implications for quantitative renographyD C Maneval, H L Magill, A M Cypess, et al.
Acta Haematologica|April 15, 1999
Adenovirus p53 purging for human breast cancer stem cell productsM Hirai, L S Kelsey, D C Maneval, et al.
Handbook of Experimental Pharmacology|December 12, 2007
HerceptinH M Shepard, P Jin, D J Slamon, et al.
Annals of Internal Medicine|January 1, 1982
Hepatic veno-occlusive disease caused by 6-thioguanineR A Gill, G R Onstad, J M Cardamone, et al.
Cancer Gene Therapy|April 19, 2000
Purging of human breast cancer cells from stem cell products with an adenovirus containing p53M Hirai, L S Kelsey, M Vaillancourt, et al.
Cancer Gene Therapy|August 7, 1998
A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growthG W Demers, M P Harris, S F Wen, et al.
Pageof 3